Cargando…
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
Reprogramming of mitochondrial functions sustains tumor growth and may provide therapeutic opportunities. Here, we targeted the protein folding environment in mitochondria by coupling a purine-based inhibitor of the molecular chaperone Heat Shock Protein-90 (Hsp90), PU-H71 to the mitochondrial-targe...
Autores principales: | Bryant, Kelly G., Chae, Young Chan, Martinez, Rogelio L., Gordon, John C., Elokely, Khaled M., Kossenkov, Andrew V., Grant, Steven, Childers, Wayne E., Abou-Gharbia, Magid, Altieri, Dario C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762502/ https://www.ncbi.nlm.nih.gov/pubmed/29348817 http://dx.doi.org/10.18632/oncotarget.23097 |
Ejemplares similares
-
LANDSCAPE OF THE MITOCHONDRIAL Hsp90 METABOLOME IN TUMORS
por: Chae, Young Chan, et al.
Publicado: (2013) -
A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)
por: Shahinas, Dea, et al.
Publicado: (2013) -
Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model
por: Vartholomaiou, Evangelia, et al.
Publicado: (2017) -
COMPARTMENTALIZED CANCER DRUG DISCOVERY TARGETING MITOCHONDRIAL Hsp90 CHAPERONES
por: Kang, Byoung Heon, et al.
Publicado: (2009) -
The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)